Exploring social determinants of health and their impacts on self-reported quality of life in long COVID-19 patients.

Publication date: Dec 06, 2024

This study explores the health-related quality of life (HRQoL) experienced by patients with Long COVD-19 using data from British Columbia’s post-COVID-19 Recovery Clinics. A retrospective cohort of 3463 patients was analyzed to assess HRQoL through the EQ-5D-5L questionnaire which includes five dimensions (mobility, self-care, usual activities, physical health, and mental health) administered to patients; responses were analyzed using the Visual Analogue Score (VAS). Notably, 95% of participants reported HRQoL scores below 90, with 50% scoring under 60, indicating significant impacts on their well-being. The analysis revealed that HRQoL is significantly influenced by various social determinants of health (SDoH), including age, sex, employment status, and ethnicity, each showing distinct correlations with HRQoL dimensions and overall VAS scores. Specifically, older age was associated with decreased mobility and increased pain/discomfort but less anxiety and depression, highlighting varying impacts across the age spectrum. The study highlights the multifaceted impacts of Long COVID on the lives of patients and underscores the necessity of targeted strategies to improve HRQoL among diverse groups, considering specific SDoH. Such a comprehensive approach could lead to more equitable health outcomes and support the development of tailored public health policies aimed at the recovery and rehabilitation of Long COVID sufferers.

Open Access PDF

Concepts Keywords
British Adult
Covid Age
Depression Aged
Patients Anxiety
British Columbia
COVID-19
Depression
Ethnicity
Female
Gender
Humans
Long COVID
Male
Middle Aged
Post-COVID syndrome
Quality of Life
Quality of Life
Retrospective Studies
SARS-CoV-2
Self Report
Surveys and Questionnaires
Young Adult

Semantics

Type Source Name
disease IDO quality
disease MESH long COVID
disease MESH COVID-19
disease MESH anxiety
disease MESH depression
disease MESH syndrome
disease MESH cognitive impairments
disease MESH brain fog
disease MESH infections
drug DRUGBANK Coenzyme M
disease IDO infection
disease IDO history
drug DRUGBANK Medical Cannabis
disease IDO role
disease MESH unemployment
disease IDO acute infection
disease IDO blood
disease MESH chronic illnesses
disease MESH living alone
drug DRUGBANK Isoxaflutole
disease MESH education level
disease MESH sequelae
drug DRUGBANK L-Aspartic Acid
disease MESH anxiety disorders
disease MESH stroke
disease MESH Privacy Act
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)